|Articles|May 1, 2001
Cyclosporin-A improves management of SJS/TEN
Palm Beach, Fla. - Low-pulse cyclosporin-A is a promising treatment for Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), Sabra Sullivan, M.D., chief of dermatology, University of Mississippi (Jackson) Medical Center, reported the annual meeting of the Noah Worcester Dermatological Society.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5













